Urinary Microbiome Changes Following Administration of 500 mg of NDS-446 in Women With Dry OAB at 12 Weeks
Condition(s):Overactive BladderLast Updated:December 11, 2023Recruiting
Include Studies Not Open or Pending
Condition(s):Overactive BladderLast Updated:December 11, 2023Recruiting
Condition(s):Bladder CancerLast Updated:December 1, 2023Not yet recruiting
Condition(s):Recurrent Urinary Tract Infection; Genitourinary Syndrome of MenopauseLast Updated:November 9, 2023Recruiting
Condition(s):Microbiota; B-lymphocytes; Glomerulosclerosis; T-lymphocytesLast Updated:June 12, 2023Recruiting
Condition(s):Microbiota in Patients With Urinary Bladder Carcinoma in Urine and Cancer TissuesLast Updated:March 1, 2024Recruiting
Condition(s):Overactive Bladder; Urgency-frequency SyndromeLast Updated:April 12, 2023Recruiting
Condition(s):Microbiota; Urinary Bladder, OveractiveLast Updated:April 14, 2022Recruiting
Condition(s):Kidney Diseases; Kidney Transplant Failure and Rejection; Urinary Tract InfectionsLast Updated:December 14, 2023Recruiting
Condition(s):Microbial ColonizationLast Updated:October 23, 2023Not yet recruiting
Condition(s):Calcium Oxalate Urolithiasis; Renal Cell CarcinomaLast Updated:September 13, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.